|

Azirkitug Clinical Trials

1 actively recruiting trial across 1 location

Also known as: ABBV-514

Pipeline

Phase 1: 1

Top Sponsors

  • AbbVie1

Indications

  • Gastric/Esophageal Cancer1
  • Micro Satellite Stable Colorectal Cancer1
  • High-grade Serous Ovarian Cancer1
  • Triple Negative Breast Cancer1
  • Pancreatic Cancer1

Duarte, California1 trial

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC) and Other Solid Tumors, Receiving Intravenous (IV) Infusion of Azirkitug (ABBV-514) Alone or in Combination With Budigalimab or Bevacizumab

City of Hope National Medical Center /ID# 276272

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.